Research graph
References from Plasma Exchange for Hantavirus Pulmonary Syndrome: A Mechanistic Case for an Untested Intervention. Local targets link to admitted publications; unresolved targets remain external evidence.
Hantavirus Pulmonary Syndrome: A Clinical Description of 17 Patients With a Newly Recognized Disease
10.1056/nejm199404073301401 · 1994 · External reference
Hantavirus Pulmonary Syndrome, United States, 1993–2009
10.3201/eid1707.101306 · 2011 · External reference
Placebo‐Controlled, Double‐Blind Trial of Intravenous Ribavirin for the Treatment of Hantavirus Cardiopulmonary Syndrome in North America
10.1086/425007 · 2004 · External reference
Extracorporeal Membrane Oxygenation Support Improves Survival of Patients With Hantavirus Cardiopulmonary Syndrome Refractory to Medical Treatment
2008 · External reference
Cardiopulmonary Manifestations of Hantavirus Pulmonary Syndrome
10.1097/00003246-199602000-00012 · 1996 · External reference
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice: Evidence‐Based Approach From the Writing Committee of the American Society for Apheresis
10.1002/jca.22043 · 2023 · External reference
Andes Hantavirus Outbreak on a Cruise Ship, 2026
10.1056/evidpha2600170 · 2026 · External reference
Hantavirus Pulmonary Syndrome: Pathogenesis of an Emerging Infectious Disease
1995 · External reference
Role of Specific CD8+ T Cells in the Severity of a Fulminant Zoonotic Viral Hemorrhagic Fever, Hantavirus Pulmonary Syndrome
10.4049/jimmunol.172.5.3297 · 2004 · External reference
High Levels of Cytokine‐Producing Cells in the Lung Tissues of Patients With Fatal Hantavirus Pulmonary Syndrome
10.1086/314597 · 1999 · External reference
Role of Mixed Th1 and Th2 Serum Cytokines on Pathogenesis and Prognosis of Hantavirus Pulmonary Syndrome
10.1016/j.micinf.2008.06.006 · 2008 · External reference
Cellular Entry of Hantaviruses Which Cause Hemorrhagic Fever With Renal Syndrome Is Mediated by beta3 Integrins
10.1128/jvi.73.5.3951-3959.1999 · 1999 · External reference
Successful Treatment of Adults With Severe Hantavirus Pulmonary Syndrome With Extracorporeal Membrane Oxygenation
10.1097/00003246-199802000-00047 · 1998 · External reference
Plasma Exchange: Concepts, Mechanisms, and an Overview of the American Society for Apheresis Guidelines
10.1182/asheducation.v2012.1.7.3797920 · 2012 · External reference
Plasmapheresis in Severe Sepsis and Septic Shock: A Prospective, Randomised, Controlled Trial
10.1007/s00134-002-1410-7 · 2002 · External reference
A Global Perspective on Hantavirus Ecology, Epidemiology, and Disease
10.1128/cmr.00062-09 · 2010 · External reference
Component Pathogen Inactivation: A Critical Review
10.1111/j.1423-0410.2012.01662.x · 2013 · External reference
Hantavirus Cardiopulmonary Syndrome Successfully Treated With High‐Volume Hemofiltration
10.5935/0103-507x.20160032 · 2016 · External reference
Extracorporeal Cytokine Adsorption in Septic Shock: A Proof of Concept Randomized, Controlled Pilot Study
10.1016/j.jcrc.2018.11.003 · 2019 · External reference
A Non‐Randomized Multicentre Trial of Human Immune Plasma for Treatment of Hantavirus Cardiopulmonary Syndrome Caused by Andes Virus
10.3851/imp2875 · 2015 · External reference
Immunopathogenesis and Treatment of Cytokine Storm in COVID‐19
10.7150/thno.49713 · 2021 · External reference
Interleukin‐1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome
10.1097/ccm.0000000000001402 · 2016 · External reference
The Efficacy and Safety of Plasma Exchange in Patients With Sepsis and Septic Shock: A Systematic Review and Meta‐Analysis
10.1186/s13054-014-0699-2 · 2014 · External reference
The Existence of Publication Bias and Risk Factors for Its Occurrence
10.1001/jama.1990.03440100097014 · 1990 · External reference
